Officer Flemming Steen Jensen sells entire 19,460-share position for $4.6M, first open-market sale in 3-year window.
Flemming Steen Jensen, an officer at Ascendis Pharma, has exited his complete shareholding through a single open-market sale, raising $4.6M. This marks his first open-market sale in the past three years, making it a notable departure from his prior inactivity on the trading front. The sale occurred when the stock was trading near its recent range—below the 52-week high but above the 52-week low—providing no obvious signal of market timing advantage. While the size of this transaction is material in absolute terms, the absence of any prior insider trading activity (buying or selling) in the historical window leaves little context for interpreting his intent: this could reflect a one-time liquidity event, a portfolio shift, or departure planning, but the data alone does not establish which.